Datavant is acquiring real-world data company Aetion to expand its life sciences business, doubling the size of its team and enhancing its ability to link clinical trials with real-world data. The deal is part of Datavant’s broader growth strategy, with plans to launch new products and pursue additional acquisitions in the healthcare data space.
Read the full article from Endpoints here.